|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VPHM |
Viropharma Inc |
10% Owner |
|
2005-04-28 |
4 |
B |
$1.79 |
$662 |
I/I |
370 |
754 |
1.42 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2005-05-10 |
4 |
B |
$2.65 |
$119 |
I/I |
45 |
799 |
1.42 |
- |
|
GHDX |
Genomic Health Inc |
N/A |
|
2006-09-07 |
4 |
B |
$13.42 |
$11,233 |
I/I |
837 |
837 |
0.01 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2005-04-28 |
4 |
B |
$1.79 |
$845 |
I/I |
472 |
923 |
1.42 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2005-05-10 |
4 |
B |
$2.65 |
$151 |
I/I |
57 |
980 |
1.42 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2005-04-28 |
4 |
B |
$1.79 |
$1,020 |
I/I |
570 |
1,175 |
1.42 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2005-05-10 |
4 |
B |
$2.65 |
$188 |
I/I |
71 |
1,246 |
1.42 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2005-04-12 |
4 |
B |
$3.57 |
$4,484 |
I/I |
1,256 |
1,256 |
1.42 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2009-02-06 |
4 |
S |
$8.17 |
$1,733 |
I/I |
(212) |
1,629 |
0 |
- |
|
PCYC |
Pharmacyclics Inc |
10% Owner |
|
2011-08-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,809 |
|
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2009-02-05 |
4 |
S |
$8.11 |
$855 |
I/I |
(105) |
1,841 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2009-02-04 |
4 |
S |
$8.01 |
$2,604 |
I/I |
(312) |
1,946 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-02 |
4 |
B |
$5.89 |
$11,999 |
I/I |
2,010 |
2,010 |
2.17 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2009-01-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(75,118) |
2,258 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2005-01-31 |
4 |
B |
$3.02 |
$7,090 |
I/I |
2,348 |
2,348 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2005-07-14 |
4 |
B |
$3.50 |
$9,723 |
I/I |
2,778 |
2,883 |
1.5 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-10-29 |
4 |
S |
$1.18 |
$17 |
I/I |
(14) |
2,902 |
0 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-10-28 |
4 |
S |
$1.19 |
$39 |
I/I |
(33) |
2,916 |
0 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-10-27 |
4 |
S |
$1.28 |
$39 |
I/I |
(30) |
2,949 |
0 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-04-23 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,979 |
|
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2005-01-31 |
4 |
B |
$3.02 |
$9,167 |
I/I |
3,036 |
3,036 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4 |
S |
$8.76 |
$901,711 |
I/I |
(102,935) |
3,998 |
0 |
- |
|
NGNE |
Neurogene |
10% Owner |
|
2015-08-07 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
4,520 |
|
- |
|
SGEN |
Seagen Inc |
Director |
|
2004-08-03 |
4 |
B |
$5.71 |
$14,840 |
I/I |
2,598 |
4,608 |
2.17 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-05-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(101,047) |
4,751 |
0 |
- |
|
1397 Records found
|
|
Page 2 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|